In this study, by establishing a clinical cohort of infective endocarditis, we observed the natural prognosis and influencing factors in the process of disease development and regression; we used multi-omics technology to understand the prognostic value of its biomarkers, and provided new ideas and evidence for the pathogenesis, clinical diagnosis and treatment of IE.
Patients with clinically confirmed infective endocarditis
Patients refuse to sign informed consent form
Patients who combined with serious systemic diseases, cannot tolerate the acquisition of biological samples
First Affiliated Hospital Xi'an Jiaotong University
Lead sponsor
521 Hospital of NORINCO Group
Collaborator
Shaanxi Provincial People's Hospital
Collaborator
Xiangyang Central Hospital
Collaborator
Henan Provincial People's Hospital
Collaborator